首站-论文投稿智能助手
典型文献
In-silico and in-vitro evaluation of docetaxel and berberine as potential p53 modulating apoptotic inducers in oral squamous cell carcinoma
文献摘要:
Objective: To investigate the interaction of p53 with docetaxel and berberine and their anticancer activities against oral squamous cell carcinoma.Methods: The interaction between p53 with docetaxel and berberine was investigated and their mechanisms of action against oral squamous cell carcinoma were studied. Toxicity studies were performed to determine any toxic impact of the drugs on the vital organs of tested animals. Results: In silico results revealed the molecular interaction of docetaxel and berberine with p53 and the molecules were found to be potential p53 inducers. Docetaxel and berberine inhibited the proliferation of cancer cells in a concentration-dependent manner. Flow cytometry analysis revealed that docetaxel and berberine at IC50 concentrations upregulated the expression of p53 in oral squamous cell carcinoma cells, thus triggering apoptotic cell death. In addition, no toxicity was observed in the liver and kidney tissues of mice after docetaxel and berberine treatment. Conclusions: Docetaxel and berberine significantly suppressed the proliferation of oral cancer cells by activating p53 expression and causing apoptotic cell death. Both compounds can be potential agents for the treatment of oral cancer, with little to no toxicity at the tissue level.
文献关键词:
作者姓名:
Smrutipragnya Samal;Rajesh Kumar Meher;Debasmita Dubey;Showkat Ahmad Mir;Binata Nayak;Mahesh Chandra Sahu;Pradeep Kumar Naik;Goutam Rath;Santosh Kumar Swain
作者机构:
Department of Otorhinolaryngology and Head and Neck Surgery,IMS and SUM Hospital,Siksha'O'Anusandhan Deemed to be University,K8,Kalinga Nagar,Bhubaneswar-751003,Odisha,India;Centre of Excellence in Natural Products and Therapeutics,Department of Biotechnology and Bioinformatics,Sambalpur University,Jyotivihar,Burla,Sambalpur,Odisha,India;Medical Research Laboratory,IMS and SUM Hospital,Siksha'O'Anusandhan Deemed to be University,K8,Kalinga Nagar,Bhubaneswar-751003,Odisha,India;School of Life Sciences,Sambalpur Univesity,JyotiviharBurla,Sambalpur,Odisha,India;ICMR-Regional Medical Research Centre,Chandrasekharpur,Bhubaneswar-751023,India;School of Pharmaceutical Sciences,Siksha'O'Anusandhan Deemed to be University,Bhubaneswar-751030,India
引用格式:
[1]Smrutipragnya Samal;Rajesh Kumar Meher;Debasmita Dubey;Showkat Ahmad Mir;Binata Nayak;Mahesh Chandra Sahu;Pradeep Kumar Naik;Goutam Rath;Santosh Kumar Swain-.In-silico and in-vitro evaluation of docetaxel and berberine as potential p53 modulating apoptotic inducers in oral squamous cell carcinoma)[J].亚太热带生物医学杂志(英文版),2022(12):530-540
A类:
B类:
In,silico,vitro,evaluation,docetaxel,berberine,potential,p53,modulating,apoptotic,inducers,oral,squamous,carcinoma,Objective,interaction,their,anticancer,activities,against,Methods,between,was,investigated,mechanisms,were,studied,Toxicity,studies,performed,determine,any,impact,drugs,vital,organs,tested,animals,Results,results,revealed,molecular,molecules,found,Docetaxel,inhibited,proliferation,cells,dependent,manner,Flow,cytometry,analysis,that,IC50,concentrations,upregulated,expression,thus,triggering,death,addition,toxicity,observed,liver,kidney,tissues,mice,after,treatment,Conclusions,significantly,suppressed,by,activating,causing,Both,compounds,agents,little,level
AB值:
0.454168
相似文献
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway
Wei-wei Liu;Fang Wang;Can Li;Xiao-yu Song;Wuxiyar Otkur;Yu-ying Zhu;Toshihiko Hayashi;Kazunori Mizuno;Shunji Hattori;Hitomi Fujisaki;Takashi Ikejima-Wuya College of Innovation,Shenyang Pharmaceutical University,Shenyang 110016,China;CAS Key Laboratory of Separation Science for Analytical Chemistry,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Department of Chemistry and Life science,School of Advanced Engineering,Kogakuin University,2665-1,Nakanomachi,Hachioji,Tokyo 192-0015,Japan;Nippi Research Institute of Biomatrix,Toride,Ibaraki 302-0017,Japan;Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang 110016,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。